EU Medical Cannabis License Granted with Strategic Agreement
Filed with ASX · · 3 pages · English
Story so far
Earlier from Argent Biopharma
- Positive MGC Derma Clinical Test Results
- CEO Appointment
- Strategic Agreement Signed with RMIT
- New EU Sales Agreements Signed For MGC Derma
- Successful MXC First Cannabinoid Production
Later from Argent Biopharma
- First European Distribution Deal Signed for API Products
- Botanical Division Update - Europe and Australia
- RMIT and MGC Pharmaceuticals Sign Strategic Agreement
- Appendix 4E and Audited 2017 Financial Report
- Major EU Pharma Supply Agreement Signed with Lenis
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma